Former OBIO CAAP company Vasomune announced an innovative global Co-Development Agreement with AnGes Inc for the development and commercialization of therapeutics treating diseases associated with blood vessel dysfunction and destabilization.
Advanced Code injection
Former OBIO CAAP company Vasomune announced an innovative global Co-Development Agreement with AnGes Inc for the development and commercialization of therapeutics treating diseases associated with blood vessel dysfunction and destabilization.